The histopathological landscape of the major psoriasiform dermatoses
Abstract
##plugins.themes.bootstrap3.article.details##
psoriasis, immune-mediated dermatitis, keratinocyte proliferation, differential diagnosis
2. Das RP, Jain AK, Ramesh V. Current concepts in the pathogenesis of psoriasis. Indian J Dermatol 2009; 54(1):7–12.
3. Weedon D. The psoriasiform reaction pattern, In Weedons Skin Pathology. 3rd edition. Churchill Livingstone; 2010:71-91.
4. Chen B, Li J, He C, et al. Role of HLA-B27 in the pathogenesis of ankylosing spondylitis. Mol Med Rep 2017; 15:1943-1951.
5. Yener GO, Tekin ZE, Yuksel S. Psoriatic fasciitis in a pediatric patient: A case report. World J Clin Cases 2019; 7(1): 69-72.
6. Uttarkar S, Brembilla NC, Boehncke WH. Regulatory cells in the skin: Pathophysiologic role and potential targets for anti-inflammatory therapies. J Allergy Clin Immunol 2019; 143(4):1302-1310.
7. Yadav K, Singh D, Singh MR. Protein biomarker for psoriasis: A systematic review on their role in the pathomechanism, diagnosis, potential targets and treatment of psoriasis. Int J Biol Macromol 2018; 118(Pt B):1796-1810.
8. Sabag AD, Dias-Polak D, Bejar J, Sheffer H, Bergman R, Vadasz Z. Altered expression of regulatory molecules in the skin of psoriasis. Immunol Res 2018; 66(6):649-654.
9. Lewis DJ, Chan WH, Hinojosa T, Hsu S, Feldman SR. Mechanisms of microbial pathogenesis and the role of the skin microbiome in psoriasis: A review. Clin Dermatol 2019; 37(2):160-166.
10. Tang L, He S, Zhu Y, et al. Downregulated miR-187 contributes to the keratinocytes hyperproliferation in psoriasis. J Cell Physiol 2019; 234(4):3661-3674.
11. Feng S, Wang L, Liu W, Zhong Y, Xu S. MiR-126 correlates with increased disease severity and promotes keratinocytes proliferation and inflammation while suppresses cells' apoptosis in psoriasis. J Clin Lab Anal 2018; 32(9):e22588.
12. Cai Y, Xue F, Quan, C, et al. A Critical Role of the IL-1β-IL-1R Signaling Pathway in Skin Inflammation and Psoriasis Pathogenesis. J Invest Dermatol 2019; 139(1):146-156.
13. Jaiswal AK, Sadasivam M, Archer NK, et al. Syndecan-1 Regulates Psoriasiform Dermatitis by Controlling Homeostasis of IL-17-Producing γδ T Cells. J Immunol 2018; 201(6):1651-1661.
14. Yan K, Han L, Deng H, et al. The distinct role and regulatory mechanism of IL-17 and IFN-γ in the initiation and development of plaque vs guttate psoriasis. J Dermatol Sci 2018; 92(1):106-113.
15. Brembilla NC, Senra L, Boehncke WH. The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond. Front Immunol 2018; 9:1682.
16. Braverman JM, Cohen I, Black MM. Metabolic and ultrastructural studies in a patient with pustular psoriasis. Br J Dermatol 1972; 105:189.
17. Shelly WB. Generalized Pustular Psoriasis: Consultations in Dermatology. Philadelphia: Saunders, 1972.
18. Gonzales-Lopez A, Velasco E, Pozo T, Del Villar A. HIV-associated pityriasis rubra pilaris responsive to triple antiretroviral therapy. Br J Dermatol 1999; 140:931-934.
19. Simon M, Flaig MJ, Kind P, et al. Large plaque parapsoriasis: Clinic and genotyping correlations. J Cutan Pathol 2000; 27:57-60.
20. Lambert WC, Everett MA. The nosology of parapsoriasis. J Am Acad Dermatol 1981; 5:373.
21. Alsaad KO, Ghazarian D. My approach to superficial inflammatory dermatoses. J Clin Pathol 2005; 58:1233–1241.
22. Rohl R, Bax D, Schierer S, Bogner PN, Hernandez-Ilizaliturri F, Paragh G. A case for histologic verification of the diagnosis of atypical psoriasis before systemic therapy. JAAD Case Rep 2018; 4(5):465-467.
23. Rapini RP. Practical Dermatopathology. 2nd Edition. Elsevier Saunders, 2012.
Archive of Clinical Cases is protected by copyright and may be used in accordance with copyright and other applicable laws. Content available at www.clinicalcases.eu and our digital applications is intended for personal noncommercial use.
Authors who submit a manuscript for publication in Archive of Clinical Cases agree to the following terms: a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) only after the final version of the manuscript was accepted and published, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). d. It is compulsory that before submission authors ensure that their work was not published in any other medical journals or pending acceptance for publication and that "Archives of Clinical Cases" is the only beneficiary at that moment if their work/case will be accepted by us.
Guidelines for linking to www.clinicalcases.eu a. The main purpose of the site linking to the Archive of Clinical Casess site should be educational. b. Links should be made to the Archive of Clinical Casess home page (www.clinicalcases.eu) or to the articles abstract. c. It is forbidden to use the Archive of Clinical Casess cover by outside organizations unless permission has been granted in advance, notifying our Secretary. d. Material owned by the Archive of Clinical Cases (including the name, logo, cover, and text) may not be used in any manner that may induce the idea or suggest that the Archive of Clinical Cases is in some way recommending a specific company, product or service. e. You must not use or allow others to access or use, all or any part of our Site or the contents and/or applications on it for commercial purposes without our permission. To seek permission to do anything prohibited by or not contained in these TERMS, or which requires our prior consent or agreement, you can contact us.